Verve Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 07, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $58,500,000
Company Info
- Founders
- Sekar Kathiresan, M.D.
- Company Description
- Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.
- Market
- Heart Disease Treatment
- Location
- Cambridge, Massachusetts, USA
- Coinvestors
- ARCH Venture Partners, Biomatics Capital, F-Prime Capital Partners, GV